Comparison of the Antiplatelet Efficacy of Aspirin Combined With Clopidogrel and Aspirin Combined With Half-dose Ticagrelor in Patients With Unruptured Intracranial Aneurysms With Normal CYP2C19 Metabolizer Phenotype
A phase 4 trial registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 196 participants.
Also called NCT06486363
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 196 participants
- Registry
-
NCT06486363
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Not reported
- Registry status
- Not yet recruiting
Technical summary
Registry record NCT06486363. Randomized; no masking; primary purpose treatment. Start 2024-08-01 (anticipated); primary completion 2026-07-31 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Comparison of the Antiplatelet Efficacy of Aspirin Combined With Clopidogrel and Aspirin Combined With Half-dose Ticagrelor in Patients With Unruptured Intracranial Aneurysms With Normal CYP2C19 Metabolizer Phenotype
- Condition
- Intracranial Aneurysms
- Condition
- Antiplatelet Drugs
- Intervention (Drug)
- Aspirin combined with clopidogrel
- Intervention (Drug)
- Aspirin combined with half-dose ticagrelor
- Lead sponsor
- The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Record details
- Record id
cardio:ct-nct06486363- Content hash
d6400222290bf8499e612fe143f89cd1ed5aa1fa6419624e2f747a88f365ae1d